Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper O. Clausen, Ken Coppieters, Janusz Gumprecht, Troels Krarup Hansen, Chantal Mathieu, Cristóbal Morales, Ofri Mosenzon,

The Lancet Diabetes & Endocrinology · 2021 · 178 citations · 28 references

DOIFull text

Open access

Concepts

References

28